Keyword: U.S. Supreme Court
Merck lost out when a judge nixed $200 million in patent damages, citing misconduct and fabricated testimony. Now it wants the Supreme Court to intervene.
An AIDS group is asking the court to consider claims that Gilead manipulated the patent system at the expense of patient safety.
Amgen's aggressive legal bid to push Sanofi and Regeneron's rival PCSK9 drug off the market didn't work, but the big biotech hasn't given up.
Appeals judges in Missouri overturned a $55 million talc powder verdict against J&J after finding the state doesn't have jurisdiction.
The U.S. Supreme Court will hear Merck's appeal in a long-running Fosamax liability fight, a move that could ripple through the pharma industry.
Merck's ruling at the Supreme Court could affect liability lawsuits across Big Pharma.
After a federal appeals court put Allergan's tribal licensing deal under review, judges scrutinized the arguments this week.
In response to the Supreme Court’s request to weigh in, the Solicitor General sided with Merck, saying that preemption should be determined by a judge, not a jury.
Dealing a blow to branded drugmakers, the U.S. Supreme Court found that inter partes review patent challenges are constitutional.
Novartis' Sandoz unit prevailed against Amgen in an appeal that's set to further shape the budding biosimilars field.